Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden
· Delayed Price · Currency is SEK 0.305
+0.013 (4.28%)
Mar 25, 2025, 1:32 PM CET
STO:LPGO Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 8.97 | 16.41 | - | 2.21 | 4.01 | 1.74 | Upgrade
|
| Revenue Growth (YoY) | -45.33% | - | - | -44.86% | 130.19% | 50701.98% | Upgrade
|
| Cost of Revenue | 23.76 | 21.52 | 31.66 | 38.25 | 8.73 | 5.41 | Upgrade
|
| Gross Profit | -14.79 | -5.12 | -31.66 | -36.04 | -4.72 | -3.67 | Upgrade
|
| Selling, General & Admin | 7.01 | 7.44 | 6.07 | 5.44 | 3.36 | 1.27 | Upgrade
|
| Other Operating Expenses | 1.12 | 0.87 | 0.39 | 0.69 | -0.26 | 0 | Upgrade
|
| Operating Expenses | 8.16 | 8.33 | 6.48 | 6.12 | 3.1 | 1.27 | Upgrade
|
| Operating Income | -22.95 | -13.45 | -38.13 | -42.16 | -7.82 | -4.93 | Upgrade
|
| Interest Expense | -0.06 | -0 | - | -0.01 | -0 | - | Upgrade
|
| Interest & Investment Income | 0.24 | 0.25 | 0.04 | 0.08 | 0.01 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.66 | 1.07 | 0.39 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | - | 0.97 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -22.11 | -12.13 | -37.71 | -41.11 | -7.82 | -4.93 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.25 | -0.05 | Upgrade
|
| Pretax Income | -22.11 | -12.13 | -37.71 | -41.11 | -8.07 | -4.99 | Upgrade
|
| Net Income | -22.11 | -12.13 | -37.71 | -41.11 | -8.07 | -4.99 | Upgrade
|
| Net Income to Common | -22.11 | -12.13 | -37.71 | -41.11 | -8.07 | -4.99 | Upgrade
|
| Shares Outstanding (Basic) | 108 | 64 | 15 | 9 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 108 | 64 | 15 | 9 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 76.61% | 336.30% | 63.10% | 104.09% | 1.84% | - | Upgrade
|
| EPS (Basic) | -0.21 | -0.19 | -2.57 | -4.56 | -1.83 | -1.15 | Upgrade
|
| EPS (Diluted) | -0.21 | -0.19 | -2.57 | -4.56 | -1.83 | -1.15 | Upgrade
|
| Free Cash Flow | -32.56 | -14.32 | -37.47 | -35.42 | -8.63 | -5.56 | Upgrade
|
| Free Cash Flow Per Share | -0.30 | -0.22 | -2.55 | -3.93 | -1.95 | -1.28 | Upgrade
|
| Gross Margin | -164.87% | -31.19% | - | - | -117.73% | -210.39% | Upgrade
|
| Operating Margin | -255.80% | -81.95% | - | -1906.83% | -195.11% | -283.24% | Upgrade
|
| Profit Margin | -246.49% | -73.92% | - | -1859.48% | -201.20% | -286.22% | Upgrade
|
| Free Cash Flow Margin | -363.00% | -87.27% | - | -1601.94% | -215.09% | -319.12% | Upgrade
|
| EBITDA | -22.92 | -13.42 | -38.11 | -42.14 | - | - | Upgrade
|
| EBITDA Margin | -255.53% | -81.81% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.02 | 0.02 | 0.02 | 0.02 | - | - | Upgrade
|
| EBIT | -22.95 | -13.45 | -38.13 | -42.16 | -7.82 | -4.93 | Upgrade
|
| EBIT Margin | -255.80% | -81.95% | - | - | -195.11% | -283.24% | Upgrade
|
| Revenue as Reported | 9.63 | 17.48 | 0.39 | 3.18 | 4.28 | 1.74 | Upgrade
|
Updated Nov 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.